LG AI Research, D&D Pharmatech partner to design oral peptides using AI (opens in new tab)

LG AI Research signed a master agreement with D&D Pharmatech on 17 June 2026, at the LG Twin Towers in Yeouido, Seoul, to jointly pursue next-generation oral peptide drug development. Attendees included Woohyung Lim, Hwayoung Lee and Jongseong Jang from LG AI Research and Seulki Lee and Sunghoon Hong from D&D Pharmatech. Under the partnership, […] The post appeared first on <a href="